There is a dearth of professionals with licenses and training to provide care for seniors’ mental and behavioral health challenges — such as Alzheimer's and other dementias, anxiety and ...
Organizations are integrating previously disparate services to better align their offerings with the shift from fee-for-service to risk-based care through visionary, member-centric solutions.
Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and challenges in women’s health. In this episode, we’re joined by Emily Lindemer, an ...
Insurers of qualified health plans on HealthCare.gov denied about one in five in-network claims and 37% of out-of-network claims in 2023, according to a new analysis from KFF. KFF is a nonprofit ...
A novel Vertex Pharmaceuticals drug that takes a new approach to pain is now approved by the FDA, a landmark decision for a first-in-class product that brings patients a treatment alternative ...
Breakthroughs in physics have reshaped everything from communications to consumer electronics. Yet these methods remain rare in medical practice, where healthcare costs continue to climb, and ...
Health data is a prime target of hackers given the value of healthcare data – in fact it is considered many times more valuable than financial data. Now, IEEE Standards Association has published ...
Hone Health, a telehealth clinic for preventive longevity care, announced Tuesday that it has raised $33 million in Series A funding, which it is using to acquire home health company ivee.
With the administration change in Washington, questions abound regarding the impact of new healthcare appointees across healthcare agencies. While it will take time to enact any presumed or ...
The onset of the Covid-19 pandemic five years ago underscored the importance of diagnostic and vaccine developers to treat and prevent infectious diseases. Infectious disease is a theme for the ...
Cargo Therapeutics, a developer of cell therapies intended to overcome cancer mechanisms that lead to relapse, is stopping its lead program after a safety complication emerged in a clinical trial ...